Description

Rapiclav 625 Tablet is a medicine that combines two active ingredients – Amoxycillin and Clavulanic Acid. It belongs to the category of antibiotics known as penicillin and beta-lactamase inhibitor combination drugs. Amoxycillin is an antibiotic that works by inhibiting the growth of bacteria, while Clavulanic Acid is a beta-lactamase inhibitor that prevents the breakdown of Amoxycillin, thereby increasing its effectiveness against resistant bacteria. Rapiclav 625 Tablet is primarily prescribed for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and dental infections. It is effective against a wide range of bacteria, both gram-positive and gram-negative. Adherence to the prescribed regimen and completion of the full course is crucial to eradicate the infection completely.

Additional information